Matches in Wikidata for { <http://www.wikidata.org/entity/Q92479617> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q92479617 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92479617 description "scientific article published on 08 August 2019" @default.
- Q92479617 description "wetenschappelijk artikel" @default.
- Q92479617 description "наукова стаття, опублікована 8 серпня 2019" @default.
- Q92479617 name "Application of ɑ-Tocotrienol-Loaded Biocompatible Precirol in Attenuation of Doxorubicin Dose-Dependent Behavior in HUH-7 Hepatocarcinoma Cell Line" @default.
- Q92479617 name "Application of ɑ-Tocotrienol-Loaded Biocompatible Precirol in Attenuation of Doxorubicin Dose-Dependent Behavior in HUH-7 Hepatocarcinoma Cell Line" @default.
- Q92479617 type Item @default.
- Q92479617 label "Application of ɑ-Tocotrienol-Loaded Biocompatible Precirol in Attenuation of Doxorubicin Dose-Dependent Behavior in HUH-7 Hepatocarcinoma Cell Line" @default.
- Q92479617 label "Application of ɑ-Tocotrienol-Loaded Biocompatible Precirol in Attenuation of Doxorubicin Dose-Dependent Behavior in HUH-7 Hepatocarcinoma Cell Line" @default.
- Q92479617 prefLabel "Application of ɑ-Tocotrienol-Loaded Biocompatible Precirol in Attenuation of Doxorubicin Dose-Dependent Behavior in HUH-7 Hepatocarcinoma Cell Line" @default.
- Q92479617 prefLabel "Application of ɑ-Tocotrienol-Loaded Biocompatible Precirol in Attenuation of Doxorubicin Dose-Dependent Behavior in HUH-7 Hepatocarcinoma Cell Line" @default.
- Q92479617 P1433 Q92479617-0B120E7B-662B-4806-A2CF-3B2FE1DF83AD @default.
- Q92479617 P1476 Q92479617-1E5B1572-4973-480F-B3A9-42D199243DD9 @default.
- Q92479617 P2093 Q92479617-6A860705-4F8D-4D4A-B152-A78EB1A554C3 @default.
- Q92479617 P2093 Q92479617-7B4BA51C-7C44-4C12-8619-92801B08710F @default.
- Q92479617 P2093 Q92479617-89FD66E8-A857-4007-89C5-ABD2138377F2 @default.
- Q92479617 P2093 Q92479617-C35B5AB3-1A38-4785-B75B-A60246CBC828 @default.
- Q92479617 P2093 Q92479617-C5E30EFE-0FE6-4C46-A764-4EDE0FAEDCB1 @default.
- Q92479617 P2093 Q92479617-E434F9EC-9539-48CC-9A23-C379BAC9BBA0 @default.
- Q92479617 P304 Q92479617-6EA34378-FDBC-4FF2-92D0-57B8E596E2EC @default.
- Q92479617 P31 Q92479617-496214EF-5044-4FF8-B982-E36559509CE2 @default.
- Q92479617 P356 Q92479617-C2AA19D3-651C-48B4-A2CB-D64B02FBD842 @default.
- Q92479617 P433 Q92479617-EEB6562D-94AA-470A-89D3-31254B65F773 @default.
- Q92479617 P478 Q92479617-0E18668E-1F23-4B8A-AA69-70485F74ADF8 @default.
- Q92479617 P50 Q92479617-A22BDE52-123F-46E2-854C-E300028ED96A @default.
- Q92479617 P577 Q92479617-30BB44F9-6471-40EC-837D-009083F627EE @default.
- Q92479617 P698 Q92479617-CB97857D-9BCD-4E7B-AC59-9E57D6707249 @default.
- Q92479617 P921 Q92479617-4C3348D0-8EAC-448F-A464-9C991D31C8F2 @default.
- Q92479617 P356 01635581.2019.1650191 @default.
- Q92479617 P698 31390910 @default.
- Q92479617 P1433 Q7070508 @default.
- Q92479617 P1476 "Application of ɑ-Tocotrienol-Loaded Biocompatible Precirol in Attenuation of Doxorubicin Dose-Dependent Behavior in HUH-7 Hepatocarcinoma Cell Line" @default.
- Q92479617 P2093 "Ailar Tupal" @default.
- Q92479617 P2093 "Fatemeh Ramezani" @default.
- Q92479617 P2093 "Maryam Mohammadi" @default.
- Q92479617 P2093 "Mehdi Sabzichi" @default.
- Q92479617 P2093 "Roya Bazzaz" @default.
- Q92479617 P2093 "Seyed Mohammadbagher Pirouzpanah" @default.
- Q92479617 P304 "653-661" @default.
- Q92479617 P31 Q13442814 @default.
- Q92479617 P356 "10.1080/01635581.2019.1650191" @default.
- Q92479617 P433 "4" @default.
- Q92479617 P478 "72" @default.
- Q92479617 P50 Q61161214 @default.
- Q92479617 P577 "2019-08-08T00:00:00Z" @default.
- Q92479617 P698 "31390910" @default.
- Q92479617 P921 Q18936 @default.